scispace - formally typeset
C

Charles E. Rupprecht

Researcher at Wistar Institute

Publications -  484
Citations -  29552

Charles E. Rupprecht is an academic researcher from Wistar Institute. The author has contributed to research in topics: Rabies & Rabies virus. The author has an hindex of 86, co-authored 475 publications receiving 27058 citations. Previous affiliations of Charles E. Rupprecht include United States Department of Health and Human Services & Global Alliance for Rabies Control.

Papers
More filters
Journal ArticleDOI

Novel lyssaviruses isolated from bats in Russia.

TL;DR: Preliminary antigenic and genetic characterization found that both rabies-related viruses discovered in Russia should be considered as new putative lyssavirus genotypes.
Journal ArticleDOI

Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis.

TL;DR: A direct rapid immunohistochemical test was evaluated under field and laboratory conditions to detect rabies virus antigen in frozen and glycerol-preserved field brain samples from northwestern Tanzania and was 100% sensitive and specific.
Journal ArticleDOI

Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition.

TL;DR: Irkut virus should be considered as a new genotype with particular relatedness to genotypes 4 and 5, and genotype 4-6, together with Aravan, Khujand and Irkut viruses, present a solid phylogroup of Old World bat lyssaviruses.
Journal ArticleDOI

Host and viral ecology determine bat rabies seasonality and maintenance

TL;DR: It is proposed that life history patterns of many species of temperate-zone bats, coupled with sufficiently long incubation periods, allows for rabies virus maintenance, and the slowing effects of hibernation on metabolic and viral activity maintains infected individuals and their pathogens until susceptibles from the annual birth pulse become infected and continue the cycle.
Journal ArticleDOI

Efficacy of rabies biologics against new lyssaviruses from Eurasia.

TL;DR: Protection was inversely related to the genetic distance between the new isolates and traditional rabies viruses, and the WCBV is the most divergent of these lyssaviruses, and neither pre-ex exposure vaccination nor conventional post-exposure prophylaxis provided significant protection.